Literature DB >> 20820770

Comparative analysis of nonaspanin protein sequences and expression studies in zebrafish.

Benoist Pruvot1, Véronique Laurens, Françoise Salvadori, Eric Solary, Laurent Pichon, Johanna Chluba.   

Abstract

Nonaspanins constitute a family of proteins, also called TM9SF, characterized by a large non-cytoplasmic domain and nine putative transmembrane domains. This family is highly conserved through evolution and comprises three members in Saccharomyces cerevisiae, Dictyostelium discoideum, and Drosophila melanogaster, and four members are reported in mammals (TM9SF1-TM9SF4). Genetic studies in Dictyostelium and Drosophila have shown that TM9SF members are required for adhesion and phagocytosis in innate immune response, furthermore, human TM9SF1 plays a role in the regulation of autophagy and human TM9SF4 in tumor cannibalism. Here we report that the zebrafish genome encodes five members of this family, TM9SF1-TM9SF5, which show high level of sequence conservation with the previously reported members. Expression analysis in zebrafish showed that all members are maternally expressed and continue to be present throughout embryogenesis to adults. Gene expression could not be regulated by pathogen-associated molecular patterns such as LPS, CpG, or Poly I:C. By bioinformatic analyses of 80 TM9SF protein sequences from yeast, plants, and animals, we confirmed a very conserved protein structure. An evolutionary conserved immunoreceptor tyrosine-based inhibition motif has been detected in the cytoplasmic domain between transmembrane domain (TM) 7 and TM8 in TM9SF1, TM9SF2, TM9SF4 and TM9SF5, and at the extreme C-terminal end of TM9SF4. Finally, a conserved TRAF2 binding domain could also be predicted in the cytoplasmic regions of TM9SF2, TM9SF3, TM9SF4, and TM9SF5. This confirms the hypothesis that TM9SF proteins may play a regulatory role in a specific and ancient cellular mechanism that is involved in innate immunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820770     DOI: 10.1007/s00251-010-0472-x

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  50 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

Review 2.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Authors:  Haifa Jabara; Dhafer Laouini; Erdyni Tsitsikov; Emiko Mizoguchi; Atul Bhan; Emanuela Castigli; Fatma Dedeoglu; Vadim Pivniouk; Scott Brodeur; Raif Geha
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

4.  A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle.

Authors:  Richard D Bagshaw; Don J Mahuran; John W Callahan
Journal:  Mol Cell Proteomics       Date:  2004-12-02       Impact factor: 5.911

5.  SOSUI: classification and secondary structure prediction system for membrane proteins.

Authors:  T Hirokawa; S Boon-Chieng; S Mitaku
Journal:  Bioinformatics       Date:  1998       Impact factor: 6.937

6.  Using CLUSTAL for multiple sequence alignments.

Authors:  D G Higgins; J D Thompson; T J Gibson
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

7.  The iodocyanopindolol and SM-11044 binding protein belongs to the TM9SF multispanning membrane protein superfamily.

Authors:  T Sugasawa; G Lenzen; S Simon; J Hidaka; A Cahen; J L Guillaume; L Camoin; A D Strosberg; C Nahmias
Journal:  Gene       Date:  2001-08-08       Impact factor: 3.688

8.  TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.

Authors:  Kiyoshi Kanazawa; Akira Kudo
Journal:  J Bone Miner Res       Date:  2004-12-20       Impact factor: 6.741

9.  Phg1p is a nine-transmembrane protein superfamily member involved in dictyostelium adhesion and phagocytosis.

Authors:  S Cornillon; E Pech; M Benghezal; K Ravanel; E Gaynor; F Letourneur; F Brückert; P Cosson
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

Review 10.  Tumor necrosis factor receptor-associated factors (TRAFs).

Authors:  J R Bradley; J S Pober
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

View more
  5 in total

1.  The nonaspanins TM9SF2 and TM9SF4 regulate the plasma membrane localization and signalling activity of the peptidoglycan recognition protein PGRP-LC in Drosophila.

Authors:  Jackie Perrin; Magda Mortier; Anne-Claire Jacomin; Perrine Viargues; Dominique Thevenon; Marie-Odile Fauvarque
Journal:  J Innate Immun       Date:  2014-08-13       Impact factor: 7.349

2.  Human TM9SF4 Is a New Gene Down-Regulated by Hypoxia and Involved in Cell Adhesion of Leukemic Cells.

Authors:  Rosa Paolillo; Isabella Spinello; Maria Teresa Quaranta; Luca Pasquini; Elvira Pelosi; Francesco Lo Coco; Ugo Testa; Catherine Labbaye
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

3.  TM9 family proteins control surface targeting of glycine-rich transmembrane domains.

Authors:  Jackie Perrin; Marion Le Coadic; Alexandre Vernay; Marco Dias; Navin Gopaldass; Hajer Ouertatani-Sakouhi; Pierre Cosson
Journal:  J Cell Sci       Date:  2015-05-21       Impact factor: 5.285

Review 4.  Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.

Authors:  Naohide Oue; Kazuhiro Sentani; Naoya Sakamoto; Wataru Yasui
Journal:  Cancer Sci       Date:  2015-07-07       Impact factor: 6.716

5.  Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene.

Authors:  Christopher R Clark; Makayla Maile; Patrick Blaney; Stefano R Hellweg; Anna Strauss; Wilaiwan Durose; Sambhawa Priya; Juri Habicht; Michael B Burns; Ran Blekhman; Juan E Abrahante; Timothy K Starr
Journal:  Sci Rep       Date:  2018-10-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.